Jiang W - Search Results

1

Dual targeted extracellular vesicles regulate oncogenic genes in advanced pancreatic cancer.

Chiang CL, Ma Y, Hou YC, Pan J, Chen SY, Chien MH, Zhang ZX, Hsu WH, Wang X, Zhang J, Li H, Sun L, Fallen S, Lee I, Chen XY, Chu YS, Zhang C, Cheng TS, Jiang W, Kim BYS, Reategui E, Lee R, Yuan Y, Liu HC, Wang K, Hsiao M, Huang CF, Shan YS, Lee AS, James Lee L. Chiang CL, et al. Among authors: jiang w. Nat Commun. 2023 Oct 23;14(1):6692. doi: 10.1038/s41467-023-42402-3. Nat Commun. 2023. PMID: 37872156 Free PMC article.

2

Advances and challenges of nanotechnology-based drug delivery systems.

Jiang W, Kim BY, Rutka JT, Chan WC. Jiang W, et al. Expert Opin Drug Deliv. 2007 Nov;4(6):621-33. doi: 10.1517/17425247.4.6.621. Expert Opin Drug Deliv. 2007. PMID: 17970665 Review.

3

Nanoparticle-mediated cellular response is size-dependent.

Jiang W, Kim BY, Rutka JT, Chan WC. Jiang W, et al. Nat Nanotechnol. 2008 Mar;3(3):145-50. doi: 10.1038/nnano.2008.30. Epub 2008 Mar 2. Nat Nanotechnol. 2008. PMID: 18654486

4

Remodeling Tumor Vasculature to Enhance Delivery of Intermediate-Sized Nanoparticles.

Jiang W, Huang Y, An Y, Kim BY. Jiang W, et al. ACS Nano. 2015 Sep 22;9(9):8689-96. doi: 10.1021/acsnano.5b02028. Epub 2015 Jul 31. ACS Nano. 2015. PMID: 26212564

5

The role of postmastectomy radiotherapy in clinically node-positive, stage II-III breast cancer patients with pathological negative nodes after neoadjuvant chemotherapy: an analysis from the NCDB.

Liu J, Mao K, Jiang S, Jiang W, Chen K, Kim BY, Liu Q, Jacobs LK. Liu J, et al. Among authors: jiang s, jiang w. Oncotarget. 2016 Apr 26;7(17):24848-59. doi: 10.18632/oncotarget.6664. Oncotarget. 2016. PMID: 26709538 Free PMC article.

6

Breaking Down the Barriers to Precision Cancer Nanomedicine.

von Roemeling C, Jiang W, Chan CK, Weissman IL, Kim BYS. von Roemeling C, et al. Among authors: jiang w. Trends Biotechnol. 2017 Feb;35(2):159-171. doi: 10.1016/j.tibtech.2016.07.006. Epub 2016 Aug 1. Trends Biotechnol. 2017. PMID: 27492049 Review.

7

Lessons from immuno-oncology: a new era for cancer nanomedicine?

Jiang W, Yuan H, Chan CK, von Roemeling CA, Yan Z, Weissman IL, Kim BYS. Jiang W, et al. Nat Rev Drug Discov. 2017 Jun;16(6):369-370. doi: 10.1038/nrd.2017.34. Epub 2017 Mar 17. Nat Rev Drug Discov. 2017. PMID: 28303024

8

Multivalent bi-specific nanobioconjugate engager for targeted cancer immunotherapy.

Yuan H, Jiang W, von Roemeling CA, Qie Y, Liu X, Chen Y, Wang Y, Wharen RE, Yun K, Bu G, Knutson KL, Kim BYS. Yuan H, et al. Among authors: jiang w. Nat Nanotechnol. 2017 Aug;12(8):763-769. doi: 10.1038/nnano.2017.69. Epub 2017 May 1. Nat Nanotechnol. 2017. PMID: 28459470

9

Immune Priming of the Tumor Microenvironment by Radiation.

Jiang W, Chan CK, Weissman IL, Kim BYS, Hahn SM. Jiang W, et al. Trends Cancer. 2016 Nov;2(11):638-645. doi: 10.1016/j.trecan.2016.09.007. Epub 2016 Oct 15. Trends Cancer. 2016. PMID: 28741502 Review.

10

Improving immune-vascular crosstalk for cancer immunotherapy.

Huang Y, Kim BYS, Chan CK, Hahn SM, Weissman IL, Jiang W. Huang Y, et al. Among authors: jiang w. Nat Rev Immunol. 2018 Mar;18(3):195-203. doi: 10.1038/nri.2017.145. Epub 2018 Jan 15. Nat Rev Immunol. 2018. PMID: 29332937 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16,135 results

Search Page